Suboptimal Adherence to Antihypertensive Treatment: Causes and Management
Stelina Alkagiet1, Konstantinos Tziomalos2
Identifiers and Pagination:Year: 2018
First Page: 41
Last Page: 45
Publisher Id: TOHYPERJ-10-41
Article History:Received Date: 8/7/2018
Revision Received Date: 14/9/2018
Acceptance Date: 5/10/2018
Electronic publication date: 23/10/2018
Collection year: 2018
open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: (https://creativecommons.org/licenses/by/4.0/legalcode). This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Suboptimal adherence to antihypertensive treatment is very common and is associated with poor control of blood pressure and increased risk for cardiovascular events. Therefore, frequent evaluation of compliance is essential in all hypertensive patients. Simplifying treatment regimens, using fixed-dose combinations and long-acting agents improves adherence, facilitates achievement of treatment targets and reduces cardiovascular morbidity and healthcare expenditures. Accordingly, physicians should be educated to implement these changes in hypertensive patients, particularly in those who require multiple antihypertensive agents to achieve blood pressure controls and in those who receive additional medications for comorbidities.